HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials.

AbstractBACKGROUND:
Circadian rhythms may influence myocardial tolerance to ischemia-reperfusion phenomena occurring during cardiac procedures. While conflicting results exist on the effect of time-of-day on surgical aortic valve replacement (SAVR), afternoon procedures could be associated with a reduced risk of death, rehospitalization or periprocedural myocardial infarction, compared with morning procedures. We examined the impact of procedure time-of-day on outcomes after transcatheter aortic valve replacement (TAVR) or SAVR.
METHODS:
We analyzed patients at intermediate- or high-surgical risk who underwent elective TAVR (n=4457) or SAVR (n=1129) in the PARTNER (Placement of Aortic Transcatheter Valve) 1 and 2 trials and registries according to time-of-day (morning versus afternoon) using the Kaplan-Meier event rates and multivariable Cox proportional hazards regression models. Sensitivity analysis was conducted using 1:1 propensity-score matching. The primary end point was all-cause death or rehospitalization at 2 years.
RESULTS:
At 2 years, no difference was observed between patients operated in the morning versus the afternoon within the SAVR (32.3% versus 30.6%, adjusted hazard ratio, 1.08 [95% CI, 0.82-1.41], P=0.58) and TAVR cohorts (35.7% versus 35.4%, adjusted hazard ratio, 1.01 [95% CI, 0.89-1.14], P=0.86) with regards to the primary end point. Rates of periprocedural myocardial infarction were low and similar between morning and afternoon in SAVR (1.6% versus 1.0%, P=0.51) and TAVR (0.4% versus 0.4%, P=0.86), as were all other clinical end points. Similar results were observed in propensity-score matched analysis.
CONCLUSIONS:
Procedure time-of-day was not associated with clinical outcomes after TAVR or SAVR. Registration: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT00530894, NCT01314313, NCT03222141, and NCT03222128.
AuthorsFlavien Vincent, Vinod H Thourani, Julien Ternacle, Bjorn Redfors, David J Cohen, Rebecca T Hahn, Ditian Li, Aaron Crowley, John G Webb, Michael J Mack, Samir Kapadia, Mark Russo, Craig R Smith, Maria C Alu, Martin B Leon, Philippe Pibarot
JournalCirculation. Cardiovascular quality and outcomes (Circ Cardiovasc Qual Outcomes) Vol. 15 Issue 1 Pg. e007948 (01 2022) ISSN: 1941-7705 [Electronic] United States
PMID35041482 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aortic Valve (surgery)
  • Aortic Valve Stenosis (diagnosis, surgery)
  • Heart Valve Prosthesis Implantation
  • Humans
  • Risk Factors
  • Severity of Illness Index
  • Transcatheter Aortic Valve Replacement (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: